Processa Pharmaceuticals, Inc.
PCSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533743
In the last 90 days, Processa Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Processa Pharmaceuticals, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 10 | 12 | +2 |
| Shares | 177.7K | 255.5K | +77.8K (+43.8%) |
| Value | $448.5K | $498.3K | +$49.9K (+11.1%) |
New holders (4)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 21,306 | $40.9K | 0.00% |
| StoneX Group Inc. | 11,437 | $29.6K | 0.00% |
| XTX Topco Ltd | 13,292 | $25.5K | 0.00% |
| Jane Street Group, LLC | 13,264 | $25.5K | 0.00% |
Sold out (2)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Citigroup Inc | 14 | $35 |
| Wells Fargo & Company | 6 | $15 |